Who We Are
PMI is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products (“RRPs”). RRPs is the term PMI uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com.
Why Invest in PMI?
PMI’s strong performance within the tobacco sector is based on: its global market leadership; a superior brand portfolio, led by Marlboro; sustainable, strong pricing power based on the company’s brands; a reasonable excise tax and manageable regulatory environment; an optimized global footprint and infrastructure; limited cost increases and significant productivity improvement opportunities; best-in-class R&D capabilities; tremendous potential for the company’s Reduced-Risk Products ¹, talented and highly-motivated employees; a strong cash flow; and a steadfast commitment to shareholder value. 1 Reduced-Risk Products ("RRPs") is the term the company uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes.